Literature DB >> 29648673

Structured Diagnostic Approach and Risk Assessment in Mucous Membrane Pemphigoid with Oesophageal Involvement.

Sandrine Benoit1, Michael Scheurlen, Matthias Goebeler, Johanna Stoevesandt.   

Abstract

Oesophageal involvement in mucous membrane pemphigoid is considered rare, but it may be underdiagnosed. To assess the incidence of oesophageal involvement in a group of patients with newly diagnosed mucous membrane pemphigoid we retrospectively analysed the medical records of 30 consecutive patients with mucous membrane pemphigoid diagnosed between 2006 and 2016 at the Department of Dermatology, University Hospital Würzburg. Twenty-one patients (70%) reported symptoms indicative of oesophageal mucous membrane pemphigoid. Twelve patients (40%) underwent oesophagogastroduodenoscopy, and oesophageal pathology compatible with mucous membrane pemphigoid was endoscopically found in 9 cases (30%). In all patients indirect and direct immunofluorescence were performed. Patients with and without oesophageal involvement did not differ with regard to the results of indirect immunofluorescence on salt-split human skin and monkey oesophagus. Study results demonstrate the necessity of a standardized diagnostic work-up, including adequate tissue samples for direct immunofluorescence, to prevent underdiagnosis of oesophageal mucous membrane pemphigoid.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29648673     DOI: 10.2340/00015555-2938

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  4 in total

Review 1.  Drug Development in Pemphigoid Diseases.

Authors:  Katja Bieber; Ralf J Ludwig
Journal:  Acta Derm Venereol       Date:  2020-02-12       Impact factor: 3.875

Review 2.  The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid.

Authors:  Mayumi Kamaguchi; Hiroaki Iwata
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

3.  A Case of Laryngeal Mucous Membrane Pemphigoid Possibly Triggered by Radiotherapy.

Authors:  Giovanni M Palleschi; Michela Di Pietro; Marta Barzacchi; Luca G Locatello; Maria B Ninu
Journal:  Indian J Dermatol       Date:  2020 Nov-Dec       Impact factor: 1.494

4.  Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine.

Authors:  William J Nahm; Michelle Juarez; Julie Wu; Randie H Kim
Journal:  J Cutan Pathol       Date:  2022-08-03       Impact factor: 1.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.